These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17613445)

  • 1. Physicians' efficacy requirements for prescribing medications to persons with Alzheimer's disease.
    Oremus M; Wolfson C; Bergman H; Vandal AC
    Can J Aging; 2007; 26(2):139-48. PubMed ID: 17613445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How physicians approach advance care planning in patients with mild to moderate Alzheimer's disease.
    Cavalieri TA; Latif W; Ciesielski J; Ciervo CA; Forman LJ
    J Am Osteopath Assoc; 2002 Oct; 102(10):541-4. PubMed ID: 12401040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in utilisation of anticholinergic drugs after initiation of cholinesterase inhibitors.
    Robinson M; Rowett D; Leverton A; Mabbott V
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):659-64. PubMed ID: 19548222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caregiver acceptance of adverse effects and use of cholinesterase inhibitors in Alzheimer's disease.
    Oremus M; Wolfson C; Vandal AC; Bergman H; Xie Q
    Can J Aging; 2007; 26(3):205-12. PubMed ID: 18238727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug prescription in mild cognitive impairment: the physicians' perspective in Italy.
    Frisoni GB; Canu E; Geroldi C; Zanetti O; Zacchi V
    Int J Geriatr Psychiatry; 2006 Nov; 21(11):1071-7. PubMed ID: 16955446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment disparities in medication prescribing for Alzheimer's: disease among ethnic groups.
    Perryman M; Lewis M; Rivers PA
    J Health Care Finance; 2009; 35(4):64-73. PubMed ID: 20515010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical treatment strategies for patients with Alzheimer's disease.
    Christensen DD; Lin P
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S17-23. PubMed ID: 18664338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment pattern of Alzheimer's disease with cholinesterase inhibitors (TRAIN study)].
    Gil-Néciga E; Gobartt AL;
    Rev Neurol; 2008 Apr 16-30; 46(8):461-4. PubMed ID: 18428102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of acetyl-cholinesterase-inhibitor (ACHEI) treatment in Alzheimer's disease: a 21-month follow-up "real world" study.
    Calabria M; Geroldi C; Lussignoli G; Sabbatini F; Zanetti O
    Arch Gerontol Geriatr; 2009; 49(1):e6-11. PubMed ID: 18768226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family physicians' recommendations for the treatment of Alzheimer's disease.
    Werner P
    Am J Alzheimers Dis Other Demen; 2006 Dec-2007 Jan; 21(6):403-10. PubMed ID: 17267372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials?
    Cortes F; Portet F; Touchon J; Vellas B
    J Nutr Health Aging; 2007; 11(4):330-7. PubMed ID: 17653493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Alzheimer's disease utilising the best available evidence-based medicine -- utopia?].
    Stoppe G; Pirk O; Haupt M
    Gesundheitswesen; 2005 Jan; 67(1):20-6. PubMed ID: 15672302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.
    Mohs RC; Shiovitz TM; Tariot PN; Porsteinsson AP; Baker KD; Feldman PD
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):752-9. PubMed ID: 19700948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary care physicians' attitudes related to cognition enhancers in early dementia: a representative eight-year follow-up study in Lower Saxony, Germany.
    Maeck L; Haak S; Knoblauch A; Stoppe G
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):415-21. PubMed ID: 17907276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing patterns for Alzheimer disease: survey of Canadian family physicians.
    Hillmer M; Krahn M; Hillmer M; Pariser P; Naglie G
    Can Fam Physician; 2006 Feb; 52(2):208-9. PubMed ID: 16926965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influences of attitudes on family physicians' willingness to prescribe long-acting opioid analgesics for patients with chronic nonmalignant pain.
    Nwokeji ED; Rascati KL; Brown CM; Eisenberg A
    Clin Ther; 2007; 29 Suppl():2589-602. PubMed ID: 18164924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer?
    Vellas B; Andrieu S; Cantet C; Dartigues JF; Gauthier S
    J Nutr Health Aging; 2007; 11(4):338-41. PubMed ID: 17653494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What Belgian geriatricians tell their patients with Alzheimer's disease and why: a national survey.
    Segers K
    Acta Neurol Belg; 2009 Dec; 109(4):283-93. PubMed ID: 20120208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of decline and evidence of subgroups in patients with Alzheimer's disease taking galantamine for up to 48 months.
    Rockwood K; Dai D; Mitnitski A
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):207-14. PubMed ID: 17621382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S
    Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.